530 HERMAN O. WEST DRIVE, EXTON, PA
Investor Presentation
Amended material disclosure
Is committed to providing timely and transparent communication to all stakeholders regarding the recent cyberattack on its network systems.
West Pharmaceutical Services Elects Eleven Directors at Annual Meeting
Financial Results, Reg. FD
Reports Fourth-Quarter and Full-Year 2025 Results
Reports Third-Quarter 2025 Results
Q1
FY 2024
Q3
Q2
FY 2023
Registration Statement for Securities to be Offered to Employees
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Additional Proxy Soliciting Materials
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Specialized Disclosure Report
S-8 POS